Popular Trials
Nutritional Intervention
Nutritional Supplements for Knee Surgery Recovery
"This trial aims to investigate whether a combination of essential amino acids and omega-3 fatty acids can help prevent muscle loss and weakness after knee surgery. The study will involve participants taking these supplements before and after
Monoclonal Antibodies
Paclitaxel +/− Cixutumumab for Esophageal Cancer
This trial is testing how well paclitaxel (a chemotherapy drug) works with or without cixutumumab (a protein-blocking drug) to treat patients with esophageal or gastroesophageal junction cancer that has spread to other parts of the body.
Popular Filters
Trials for Breast Cancer Patients
Alkylating agents
Chemotherapy +/− Bevacizumab for Breast Cancer
This trial is testing doxorubicin hydrochloride, cyclophosphamide, and paclitaxel with or without bevacizumab to see how well they work in treating patients with lymph node-positive or high-risk, lymph node-negative breast cancer.
Trials for LABC Patients
Alkylating agents
Chemotherapy +/− Bevacizumab for Breast Cancer
This trial is testing doxorubicin hydrochloride, cyclophosphamide, and paclitaxel with or without bevacizumab to see how well they work in treating patients with lymph node-positive or high-risk, lymph node-negative breast cancer.
Trials for HER2 Positive Patients
Alkylating agents
Chemotherapy +/− Bevacizumab for Breast Cancer
This trial is testing doxorubicin hydrochloride, cyclophosphamide, and paclitaxel with or without bevacizumab to see how well they work in treating patients with lymph node-positive or high-risk, lymph node-negative breast cancer.
Monoclonal Antibodies
Paclitaxel + Trastuzumab + Pertuzumab for Inflammatory Breast Cancer
This trial is testing the safety and effectiveness of an investigational drug to see if it works in treating a specific cancer. The drug, pertuzumab, is being studied in combination with paclitaxel and trastuzumab as a preoperative treatment for inflammatory breast cancer.
Trials for ER Positive Patients
Alkylating agents
Chemotherapy +/− Bevacizumab for Breast Cancer
This trial is testing doxorubicin hydrochloride, cyclophosphamide, and paclitaxel with or without bevacizumab to see how well they work in treating patients with lymph node-positive or high-risk, lymph node-negative breast cancer.
Phase 3 Trials
Alkylating agents
Chemotherapy +/− Bevacizumab for Ovarian Cancer
This trial is studying carboplatin, paclitaxel, and gemcitabine hydrochloride given together with or without bevacizumab after surgery to treat patients with ovarian, epithelial, primary peritoneal, or fallopian tube cancer.
Alkylating agents
Chemotherapy +/− Bevacizumab for Breast Cancer
This trial is testing doxorubicin hydrochloride, cyclophosphamide, and paclitaxel with or without bevacizumab to see how well they work in treating patients with lymph node-positive or high-risk, lymph node-negative breast cancer.
Trials With No Placebo
Stem Cell Therapy
Bio ACL Reconstruction for Anterior Cruciate Ligament Rupture
This trial tests a collagen membrane from amniotic tissue to help heal ACL reconstructions. It targets patients with slow or incomplete healing. The membrane keeps helpful cells and growth factors near the graft, speeding up recovery and strengthening the new ligament. Amniotic membranes are known for their anti-inflammatory, scaffolding, and stem cell-producing effects, which can aid in the healing process of ACL reconstructions.
Alkylating agents
Chemotherapy +/− Bevacizumab for Ovarian Cancer
This trial is studying carboplatin, paclitaxel, and gemcitabine hydrochloride given together with or without bevacizumab after surgery to treat patients with ovarian, epithelial, primary peritoneal, or fallopian tube cancer.
View More Related Trials
Frequently Asked Questions
Introduction to acl
What are the top hospitals conducting acl research?
When it comes to cutting-edge clinical trials for the treatment of ACL (anterior cruciate ligament) injuries, several top hospitals are leading the way. In Burbank, California, Providence Saint Joseph Medical Center/Disney Family Cancer Center is at the forefront with nine active ACL trials. This hospital and research center, located in close proximity to the glitz and glamour of Hollywood, is making strides in advancing medical knowledge on this common sports-related injury. Moving across the country to Newark, Delaware, Christiana Care Health System-Christiana Hospital is also heavily involved in ACL research with eight ongoing trials. Serving as a major healthcare provider in Delaware and neighboring states, this institution plays a crucial role in understanding and improving treatments for athletes suffering from ACL injuries.
In Colorado Springs at Penrose-Saint Francis Healthcare, researchers are conducting seven active clinical trials focused on ACL injuries. This picturesque location nestled near the Rocky Mountains offers an ideal backdrop for exploring innovative approaches to treating these debilitating knee conditions. Meanwhile, Porter Adventist Hospital in Denver has also made significant contributions with seven ongoing acl trials.The bustling city of Denver provides an urban setting where medical professionals can collaborate on groundbreaking acl studies.
Not too far away lies Lakewood where Saint Anthony Hospital is actively engaged in seven current acl trials.As part of their commitment towards bettering public health by researching such critical areas; they have been steadily contributing through years continuing their consecutive participation over time
These hospitals may not have conducted any historical acl trails; however,the fact that they are undertaking multiple simultaneous studies highlights their dedication to finding new solutions for patients living with ACL injuries. By pushing boundaries and exploring novel approaches through these clinical trials ,these institutions aim bring long-lasting improvements to those who suffer from one of the most common sports-related knee ailments
Which are the best cities for acl clinical trials?
When it comes to ACL clinical trials, several cities emerge as leaders in research and development. Anchorage, Alaska leads the way with 43 active trials studying various treatments like Bevacizumab, Ramucirumab, and Quality-of-Life Assessment. Denver, Colorado closely follows with 37 ongoing studies focused on interventions such as Bevacizumab, Paclitaxel, and Trastuzumab. Lastly, Los Angeles offers a vibrant hub for ACL trials with 30 active studies exploring treatments like Paclitaxel, Bevacizumab, and Carboplatin. These cities provide individuals seeking innovative solutions for ACL issues access to cutting-edge clinical trials that can potentially enhance quality of life and advance treatment options.
Which are the top treatments for acl being explored in clinical trials?
Clinical trials are paving the way for innovative treatments in ACL (anterior cruciate ligament) injuries. One promising contender is platelet-rich plasma therapy, a non-surgical option that utilizes the patient's own blood to promote healing. Another potential treatment being explored is mesenchymal stem cell therapy, which involves injecting specialized cells into the damaged area to encourage tissue repair. Lastly, there are ongoing trials investigating the efficacy of bioabsorbable implants, which can provide mechanical support during recovery and gradually dissolve over time. With these advancements on the horizon, patients with ACL injuries may soon have more effective and personalized treatment options available to them.
What are the most recent clinical trials for acl?
Exciting developments in ACL research are shedding light on potential breakthroughs for treatment. One notable clinical trial involves a combination of ACL repair, Exparel, and nerve block therapy. The aim is to assess the effectiveness of this approach in promoting successful outcomes post-surgery. Additionally, another study explores the use of Zoledronic Acid Injection as a possible intervention for ACL injuries. Furthermore, researchers are investigating the efficacy of an iNOS inhibitor and nab-paclitaxel in conjunction with alpelisib for treating ACL patients. Another trial examines VCN-01 combined with standard care treatments to determine its impact on patient recovery and rehabilitation following an ACL injury. Lastly, Linaclotide is being evaluated in a Phase 3 study to gauge its potential benefits for individuals with ACL issues. These trials offer hope for improved management strategies and enhanced quality of life among those affected by ACL injuries.
What acl clinical trials were recently completed?
Recent advancements in the field of ACL research have led to the completion of several important clinical trials. These studies focused on evaluating new treatments and techniques for addressing anterior cruciate ligament (ACL) injuries. While specific details may vary, these recent completed trials highlight the continued efforts of researchers to improve outcomes and enhance rehabilitation strategies for individuals with ACL tears.